Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program

    NEXT STORY
    Insights on the Over-the-Counter Drugs Global Market to 2025 – Growing Number of Patent Expirations Presents Opportunities
    PREV STORY
    Translate Bio to Participate in Upcoming Investor Conferences
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing

    author_avatar
    NASDAQ Market News

    La Jolla Pharmaceutical Company Announces LJPC-401 Presentations at 23rd Congress of the European Hematology Association

    SAN DIEGO, May 17, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq:LJPC), a ...

    author_avatar
    NASDAQ Market News

    ChemoCentryx Reports Third Quarter 2019 Financial Results and Recent Highlights

    author_avatar
    NASDAQ Market News